ARCH Venture Fund XII, L.P. - Insider Non-Derivative Transactions at Prime Medicine, Inc. (PRME) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Aug 1, 2025, ARCH Venture Fund XII, L.P.'s relationship to Prime Medicine, Inc. (PRME) is TenPercentOwner, and currently has 6,230,300 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other PRME insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

ARCH Venture Fund XII, L.P. - Insider Non-Derivative Transactions of PRME Common Stock

ARCH Venture Fund XII, L.P. - Insider Non-Derivative Transactions at PRME

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Aug 2, 2025	P -- (Common Stock)	3030300	3.3	6230300